{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-050120","form_type":"8-K","ticker":"USAQ","cik":"0000856984","company_name":"QHSLab, Inc.","filed_at":"2024-12-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.162272+00:00","generated_at":"2026-05-29T03:12:50.128706+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"QHSLab projects $10M revenue with 250-300 physicians at >65% gross margins","bullets":["Single provider using full suite can generate $30-50k annual revenue for QHSLab.","Allergy kits ~$100/test; immunotherapy ~$500/patient/year; digital tools $20-40/patient.","Targeting 250-300 physicians to drive over $10M annual revenue at >65% gross margins.","Paid $215k to Mercer debt from cashflow; plans to eliminate debt with new capital.","Expanding sales force by 5 reps in TX, GA, NY; QHS Behavioral Centers by Q2 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-050120","json":"https://secwatch.observer/filing/0001493152-24-050120.json","markdown":"https://secwatch.observer/filing/0001493152-24-050120.md","text":"https://secwatch.observer/filing/0001493152-24-050120.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/856984/000149315224050120/0001493152-24-050120-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/856984/000149315224050120/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T03:12:50.128706+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}